高鍶礦泉水研究簡報

瀘云礦水限司研簡一長江雪嶺鍶礦泉水對養(yǎng)人肝細胞增及功能的影目胞LO2增殖和方：LO2MTT法檢測其增殖活力，并測定培養(yǎng)上清液中AST、ALT的代于96孔板每孔的細胞×10

/ml、4mg/L、6mg/L含含鍶的2mg/L、4mg/L組、6mg/L組和8mg/L組2天、天和用MTT并在第4天取培定AST及結：胞3天后2mg/L4mg/L6mg/L8mg/L組肝細接種5天與空白組相

中4mg/L和6mg/L組種7天后6mg/L差異中AST及ALT異具、2mg/L及6mg/L組AST及ALT酶2mg/L與空白組比較對照、、6mg/L組培養(yǎng)差異具顯著性中6mg/L組總膽紅在一定濃鍶礦低ASTALT酶年10月18日/p>

瀘云礦水限司研簡二長江雪嶺鍶礦泉水對Wistar大鼠Ⅰ型糖尿的影響可現(xiàn)代科學已證實糖尿病與人（strontium,Sr）39微克，成年人鍶2鍶與疾病高鍶wistar大鼠I型≥目：對I型糖尿病大鼠的血糖方：克，雄雌各半，一次性（STZ）60復制I型糖尿病模型3天

達（DM鼠DM鼠隨機Sr2mg/L（組）、Sr4mg/L（B組）組Sr6mg/L長C長組DM組(N=32)DM組分別于第12個月、第34個月隨機處死游離結：（GLu血乳酸（LD第1、2、3、4，、、C、D與DM組（P>0.05白GHb)1月，B、組糖化血紅蛋白較DM（2、、4月，A、、C、D組（NEFA1、月，、、C、D組均較組明顯（3、月，D組較（1月組均較DM組明顯P<0.05D（P<0.012月，DM組明顯（3、月A、、、與DM

醇1月，、、、與DM第2，組DM34A組DM組比較結：在型糖油對型糖I病年10月18/p>

瀘云礦水限司研簡三不同濃度長江雪嶺高礦泉水對HK-2細胞增殖及的影響背目前定范圍內(nèi)高濃度的鍶對人體健康是目：HK-2人其方代于96孔板為5×104/ml8h含鍶礦泉水、6mg/L含的DMEM培養(yǎng)2mg組組、37℃、296h和育4h，出現(xiàn)溶解液100ul，置于長570nm處讀取OD.根據(jù)吸光值并65×4/ml24h

8個復孔。-20融次，刮刀收集測ATP酶活性。果：和6mg/L濃度的含細胞的增（p<0.05濃力P<0.05)。4mg/L6mg/L能年10月18日/p>

瀘云礦水限司研簡四長江雪嶺鍶礦泉水對尿酸血癥（痛風）大鼠的影響strontium，，成年目方：年Wistar大鼠200只200206克克體第0第20顯示隨后+

為的+飲水、高尿酸血癥模型組

單獨飲水組別嘌呤醇+飲水組

自來水組4mg/L鍶礦泉水組6mg/L鍶礦泉水組8mg/L鍶礦泉水組別嘌呤醇治療自來水組別嘌呤醇治療+鍶礦泉水組別嘌呤醇治療+鍶礦泉水組別嘌呤醇治療+鍶礦泉水組醇100mg/kg灌喂組第1246周8取8血肌處死結：1P<0.05+各高鍶礦泉水組與別嘌呤治療+（P（P>0.052療+各高療尿（P>0.05嘌呤治+療+P<0.05

療后療后周別療療4mg/L鍶P療第周。江雪含為的高測病理生理學教研室年10月16日/p>

TheBrief1TheEffectofChangJiangMountainsHighConcentrationMineralOnLiverLO2Proliferationand:TotheofdifferentonhepatocytesproliferationandPreparedculturemediumswaterscontainingandcellstheCellproliferationwasanalyzedbyMTTassay;ASTandALTactivitycontentoftotalbytestkitTheproliferationofCellshowedsignificantdifferences3ineachgroup.thetheofwater,2mg/Land4mg/LgroupcanenhanceproliferationofLO2cellsignificantly,comparedthe,proliferationof6mg/Lgroupnodifference,andlag;Atdaysthetheandeachofthedifferentofstrontium-containingstimulatethecellproliferation,4mg/L6mg/Lcomparedaredifference.At7daysinadditionthethegroupsshowncertaindegreeofinhibition,proliferationof4mg/Land6mg/Lstillbettergroups,but8mg/Lgroupshowed

inhibition.ComparedwiththetheASTandALTactivityofcontrolgroupandwerelower,butthenon-significantbetweenthecontrol2mg/L,4mg/L6mg/LASTandALTactivity8mg/Lwasgroups.totalcontentof2mg/Lhigherthantheothergroupssignificantly;theblankthecontrol4mg/L6mg/Lgroupand8mg/Lgrouptotalwere6mg/Lminimum.Inarangeofconcentration,enhanceculturedcell(LO2)proliferation;canandALTactivityreduceandenhancetheofstrontium;humancellproliferation;ALT;AST;totalbilirubin.ofLuZhoumedical18.Oct.2011

TheBrief2oftheChangJiangSnowyMineralWaterwithConcentrationonTypeIModelsoftraceandtheofbodythefieldsinternationalscientificSomearerelatedtoandconditionofglucoseintheconfirmed,thelackofbodyessentialtracesuchchromium,selenium.that,belongsthemetal,andisalsoakindoftraceelementhumanbody.contentofSr39ug/Lintheblood,andThereislittlestudyabouttheofSrandlittlereportabouttheEffectoftheonstudywastodiscusstheofChangMountainsWaterHighConcentration(cantheevidencetherelationshipSrandTotheofChangMountainsdifferentofoncontentbloodglucose,bloodlactictriglycerides,fattyinI’220~250g,halfmalehalf

theexperiment.injectionofStreptozotocin(STZ)60mg/kgwasdayslater,thefastingglucosethediabetes(DMThenDMrandomlydividedA,ratsdrinkingChangMountainsWaterConcentrationSr2mg/LratsdrinkingChangMoutains4mg/L;groupC,drinkingSnowyMoutanisnaturalSr6mg/L;groupD,ratsdrinkingChangMoutainsnaturalmineral8mg/LDMratsdringkingwater,ratsineachgroup(N=32).ineachgroupaftermonth,thesecondthethirdmonths,andfourthmonthwererandomlyandbloodcollected.Thenthebloodofbloodglycosylatedtriglycerides,fattyinsulin.Therenodifferencethecontentofbloodglocoseacid(LD),insulinbetweenA,B,andDMatend1,2,mo.(>(GHb):Attheof1theofglycatedhemoglo-bingroupDMgroup(PAtthe3,mo,theredifferenceA,C,groupandDMFreefattyacid:Attheend1,2ofNEFAinA,B,wereobviouslythanDMgroup(<Attheendof3mo,theofNEFAinthanDM(<0.05).Triglycerides(TG):Atendof1mo,ofTGinwereobviouslydecreasedcomparedtoDM(PespeciallyingroupD(<Attheendofmo,theof

inthanDMgroup<Attheend3,4therenobetweenA,C,andDM(TC):Atendof1theresignificantbetweenA,B,C,DandDMAtcontentofTCinthanDM(P<0.05);Attheof3andmo,therewasnobetweenB,C,andDMMountainsHighConcentrationansignificantreducingblood-lipoidsIdiabetestheearlystage,obviouslyofnon-esterifiedfattyMountainsHighConcentrationnoofreducingglycatedImellitusMountainsConcentrationnotheofIofPathophysiologymedicalcollege18.Oct.2011

TheBrief3TheEffectofChangJiangMountainsMineralWaterConcentrationonHK-2CellsProliferationandtheActivityofATPEnzymeBackground:Alevelstrontiumtheofhumanbeing,however,notreporteffectstrontiumtheeffectofwaterscontainingdifferentstrontiumcellproliferationandATPenzymeactivity.Preparedthemediumswaterscontainingdifferentculturedcellsthem.CellproliferationbyMTTassay,ATPactivitywasbyATPHK-2cellioncycleprolongedbythestrontiumwaters4mg/Landsixmg/LSrsignificantly,theprosperousproliferationbemorelongerthanblanket<0.05);Strontiumwater2-8mg/LSrcanenhancecellsATPenzymeactivity(p0.05).mineralwater4mg/LSrgood

ofLuZhoumedical18.Oct.2011

TheBriefReport4TheEffectsofChangjiangSnowyMountainsStrontiumhyperuricemiaHyperuricemiaisadiseasehazardstohealthseriously.showntraceelementsrelateddiseases,asdiabetes.(Sr)akindessentialbody.Normalcontent39ug/Linblood.AneedsmgSreveryonrelationshipSrandisalittle,theConcentrationonhyperuricemianotresearchratstohyperuricemiaordertostudytheofChangjiangMountainsStrontiumohyperuricemia(gout).Itwillexperimentalto(gout).TotheofMountainsConcentrationStrontiumonhyperuricemia(gout)throughbloodnitrogenuricacid.Methods:adult±wererandomly

intohyperuricemiagroup.Thehyperuricemiagroupgivenmixturewithyeastaof6g/100gbodydays.groupwerefedratequivalently.Inthe10and20bloodinweretoacidlevel.20daysuricofmixedfedwerehigherthanthatintheitshowedhyperuricemiamodelweresuccessfully.Thenratsinhyperuricemiagrouprandomlydividedintodrinkinggroupand+groupincludedstrontiumquantitymg/L,mg/L,groupandtapAstableinallopurinol+drinkinggroupwerefed100mg/kgbodyweight.Allfednormalfodder.ratswerethe2weeks,weeks.SerumureanitrogenbloodandxanthineoxidasewereandwereassessedbyTable:groupwererandomlyintogroup

tapwatergroupDrinking4mg/LSrmineralgroupwatergroup6mg/LSrmineralgroup8mg/LSrmineralgroupAllopurinolallopurinolgroup

drinkingwatergroup

SrmineralgroupSrmineralgroupSrmineralgroup(1)1uricofdrinkingmineralStrontiumgroupswere<0.05)thantapuricofallopurinol+drinkingConcentration(p<allopurinol+drinkingtapcreatinine,andnitrogeneachno(2)2treatment,drinkingwaterno(P>0.05);uricacidofallopurinol+drinkinggroups